What is the main business of Revitalife?

The main business activity of Revitalife focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 22, 2017.

Where is the headquarters located?

The headquarters is located at: ul. Rabindranatha Tagore 3, 02-647 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2021 to December 31, 2021.

What was the revenue?

In 2021, the company's revenue reached $4,474.

No, the company recorded a net loss of $1,831 in 2021. For comparison, in 2020 the loss was $3,089, meaning the company reduced its loss by 41.2%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $4,606 in 2021, representing 76% of all operating expenses.

Revitalifesp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2017-09-22

Share capital

5 000,00 PLN

Registered address

ul. Rabindranatha Tagore 3/2.3, 02-647 Warszawa, Poland

Financials

Revenue history

Filing timeliness

No financial statement for 2022 – the filing deadline has passed. 1 of 4 financial statements was filed late (for 2021, 59 days late).

2022not filed
202112/09/2022
202007/09/2021
201909/09/2020
201828/06/2019

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2021.

Results vs industry

Revenue

This companyUSD 4.47kMedianUSD 443.18kAverageUSD 1.74m

Net profit

This companyUSD -1.83kMedianUSD 14.27kAverageUSD 128.63k

Operating costs

This companyUSD 6.05kMedianUSD 395.77kAverageUSD 1.56m

Assets

This companyUSD 6.27kMedianUSD 173.69kAverageUSD 1.02m

Industry

Authorized Representatives

Anna Walszewska – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Ewa Krystyna Solipiwkoage 40	50	$675.31	50%
Anna Walszewskaage 47	50	$675.31	50%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication date	Event
Oct 11, 2024	Dissolution without liquidation opened

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Nectar Polskasp. z o.o.	$528,123.00	klinikametoda.pl
Astimedsp. z o.o.	$498,540.18	astimed.pl
I. V. Clinicsp. z o.o.	$510,444.80	ivclinic.com.pl
MAAMsp. z o.o.	$455,593.52	urmed.pl
Saska Medsp. z o.o.	$241,826.45	saskamed.pl
Promindsp. z o.o.	$89,181.48	promindclinic.pl
Onkomedicasp. z o.o.	$69,344.55	onkomedica.pl
Biocells Medicalsp. z o.o.	$11,508.17	biocellsmedical.com
Bodyclinicsp. z o.o.	$3,758.46	bodyclinic.pl
Regenerumclinicsp. z o.o.	$1,427.86	regenerumclinic.pl